| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |